MarketPeel
Insider Trading Intelligence
MS

Mark C. Schneyer

ACAD
EVP, CHIEF FINANCIAL OFFICER · ACADIA PHARMACEUTICALS INC · CIK 0001899977
FILING MIX · LIFETIME45%/55%
BUYS
40
SELLS
48
TOTAL VALUE
$2.79M
COMPANIES
1
ACTIVE SINCE
Feb 2022
HOLDINGS NOW
66,145
AVG SELL PX
$21.47
TRADE KIND
SHOWING 88 / 88
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
28 backtested trades · 8 horizons · 30 pending
Forward-return performance of every backtestable P/S trade by Mark C. Schneyer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d28+50.00%+0.70%+0.81%-0.11%-1.58%
14d28+50.00%+0.16%+1.07%-0.91%-0.87%
30d28+53.57%+1.02%+3.23%-1.95%-5.33%
60d28+57.14%+3.45%+4.12%+0.05%-4.30%
90d28(2 pending)+34.62%+7.49%+6.54%+0.94%+1.80%
180d28(5 pending)+56.52%+4.65%+10.85%-6.20%-13.45%
1y28(8 pending)+55.00%+6.91%+18.95%-12.04%-16.52%
2y28(15 pending)+46.15%+4.14%+39.01%-34.87%-43.05%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ACAD · 66,145 shares · as of May 4, 2026
027,69055,38183,071110,7612023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 40 buys / 48 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
3,506$21.79$76.4K66,145May 4, 2026May 5, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
6,81569,651May 1, 2026May 5, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
6,8156,815May 1, 2026May 5, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
2,709$22.20$60.1K62,836Apr 7, 2026Apr 7, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
5,27665,545Apr 5, 2026Apr 7, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
5,2760Apr 5, 2026Apr 7, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
3,171$21.65$68.7K60,306Mar 26, 2026Mar 26, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
37$21.72$80460,269Mar 26, 2026Mar 26, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
6,17863,477Mar 25, 2026Mar 26, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
4,177$21.47$89.7K57,299Mar 25, 2026Mar 26, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
6,17812,358Mar 25, 2026Mar 26, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
8,13861,476Mar 24, 2026Mar 26, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
8,13824,414Mar 24, 2026Mar 26, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
26,38226,382Mar 6, 2026Mar 10, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
90,69190,691Mar 6, 2026Mar 10, 2026View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
10,262$23.69$243.1K53,338Nov 18, 2025Nov 19, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
9,9130Nov 17, 2025Nov 19, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
9,91363,600Nov 17, 2025Nov 19, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
9,91353,687Nov 17, 2025Nov 19, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
3,498$23.65$82.7K43,447Sep 15, 2025Sep 16, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,81546,945Sep 12, 2025Sep 16, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
22,000$25.18$554.0K40,130Aug 18, 2025Aug 19, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
2,000$25.00$50.0K62,130May 16, 2025May 19, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
3,498$14.60$51.1K62,773May 2, 2025May 2, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
6,81513,630May 1, 2025May 2, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
6,81566,271May 1, 2025May 2, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
2,708$14.82$40.1K59,456Apr 8, 2025Apr 8, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
5,2755,276Apr 5, 2025Apr 8, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
5,27562,164Apr 5, 2025Apr 8, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
3,171$17.05$54.1K56,889Mar 26, 2025Mar 26, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
6,17860,060Mar 25, 2025Mar 26, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
6,17818,536Mar 25, 2025Mar 26, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
110,761110,761Mar 24, 2025Mar 26, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
32,55232,552Mar 24, 2025Mar 26, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
773$19.96$15.4K53,882Feb 24, 2025Feb 25, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
1,35354,655Feb 23, 2025Feb 25, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
1,3530Feb 23, 2025Feb 25, 2025View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
10,259$16.81$172.5K53,302Nov 19, 2024Nov 19, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
9,91363,561Nov 17, 2024Nov 19, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
9,91353,648Nov 17, 2024Nov 19, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
9,9139,913Nov 17, 2024Nov 19, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
9,733$15.28$148.7K43,735Aug 19, 2024Aug 20, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,27539,839Aug 16, 2024Aug 20, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,62953,468Aug 16, 2024Aug 20, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
975$14.79$14.4K34,564Jun 10, 2024Jun 11, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
1,8930Jun 8, 2024Jun 11, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
1,89335,539Jun 8, 2024Jun 11, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
3,503$16.94$59.3K32,053May 2, 2024May 3, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
6,81420,445May 1, 2024May 3, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
6,81435,556May 1, 2024May 3, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
2,716$17.87$48.5K28,742Apr 8, 2024Apr 9, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
5,27531,458Apr 5, 2024Apr 9, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
5,27510,551Apr 5, 2024Apr 9, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
5,434$17.90$97.3K26,183Mar 27, 2024Mar 27, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,55031,617Mar 25, 2024Mar 27, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
24,71424,714Mar 25, 2024Mar 27, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
80,56480,564Mar 25, 2024Mar 27, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
772$24.67$19.0K21,067Feb 26, 2024Feb 27, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, CHIEF FINANCIAL OFFICER
1,35321,839Feb 23, 2024Feb 27, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, CHIEF FINANCIAL OFFICER
1,3531,353Feb 23, 2024Feb 27, 2024View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
5,108$22.64$115.6K20,486Nov 20, 2023Nov 21, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
4,95619,826Nov 17, 2023Nov 21, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, Chief Financial Officer
4,95620,638Nov 17, 2023Nov 21, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, Chief Financial Officer
4,95625,594Nov 17, 2023Nov 21, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
10,000$29.00$290.0K15,682Aug 21, 2023Aug 23, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
1,8931,893Jun 8, 2023Jun 12, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, Chief Financial Officer
1,89323,798Jun 8, 2023Jun 12, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
974$25.02$24.4K22,824Jun 8, 2023Jun 12, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, Chief Financial Officer
14,86937,215May 17, 2023May 19, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, Chief Financial Officer
14,86922,346May 17, 2023May 19, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
14,86924,782May 17, 2023May 19, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
15,310$22.50$344.5K21,905May 17, 2023May 19, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
89,93689,936May 1, 2023May 3, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
27,25927,259May 1, 2023May 3, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
1,916$18.16$34.8K7,477Apr 6, 2023Apr 7, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
5,27515,826Apr 5, 2023Apr 7, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, Chief Financial Officer
5,2759,393Apr 5, 2023Apr 7, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
577$18.78$10.8K4,118Feb 24, 2023Feb 27, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
1,3532,706Feb 23, 2023Feb 27, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, Chief Financial Officer
1,3534,695Feb 23, 2023Feb 27, 2023View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
653$17.91$11.7K3,342Jun 9, 2022Jun 10, 2022View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
EVP, Chief Financial Officer
1,8933,786Jun 8, 2022Jun 10, 2022View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
EVP, Chief Financial Officer
1,8933,995Jun 8, 2022Jun 10, 2022View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
21,10121,101Apr 5, 2022Apr 7, 2022View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
72,41472,414Apr 5, 2022Apr 7, 2022View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
Chief Financial Officer
1,3522,655Feb 23, 2022Feb 25, 2022View →
ACAD
ACADIA PHARMACEUTICALS INC
PURCHASE
Chief Financial Officer
1,3524,059Feb 23, 2022Feb 25, 2022View →
ACAD
ACADIA PHARMACEUTICALS INC
SALE
Chief Financial Officer
553$23.80$13.2K2,102Feb 23, 2022Feb 25, 2022View →
Other insiders · ACAD
Loading peer insiders…
About this filer
CIK 0001899977
ROLE
EVP, Chief Financial Officer
PRIMARY
ACAD
COMPANIES
1
ACTIVE SINCE
Feb 2022
MARKETPEEL · /INSIDER/0001899977DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback